Exploring the Link Between Ankylosing Spondylitis and Inflammatory Bowel Disease: A Retrospective Cohort Study

被引:0
|
作者
Sharif, Kassem [1 ,2 ,3 ,4 ]
Lahat, Adi [1 ,2 ,3 ,4 ]
Shneor, Yonatan [1 ,2 ,4 ]
Ben-Shabat, Niv [1 ,2 ,4 ]
Omar, Mahmud [1 ,2 ,4 ]
Watad, Abdulla [1 ,2 ,4 ,5 ,6 ]
Amital, Howard [1 ,2 ,4 ]
Gendelman, Omer [1 ,2 ,4 ]
机构
[1] Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel
[2] Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Hashomer, Israel
[3] Sheba Med Ctr, Dept Gastroenterol, Tel Hashomer, Israel
[4] Tel Aviv Univ, Fac Med, Tel Aviv, Israel
[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Dept Musculoskeletal Dis, Leeds, England
[6] Leeds Teaching Hosp, Natl Inst Hlth Res NIHR, Leeds Biomed Res Ctr BRC, Leeds, England
来源
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2024年 / 26卷 / 04期
关键词
ankylosing spondylitis (AS); Crohn's disease; inflammatory bowel disease (IBD); ulcerative colitis; ARTHROPATHIES; PREVALENCE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are chronic conditions with overlapping pathogenic mechanisms. The genetic predisposition and inflammatory pathways common to both diseases suggest a syndemic relationship. While some evidence points to a connection between the two conditions, other reports do not support this link. Objectives: To investigate the association between AS and the subsequent incidence of IBD. To identify potential risk factors and effect modifiers that contribute to this relationship. Methods: Utilizing the Chronic Disease Registry of Clalit Health Services, we conducted a retrospective cohort study of individuals diagnosed with AS between January 2002 and December 2018. We compared these patients with age- and sex -matched controls, excluding those with a prior diagnosis of IBD. Statistical analyses included chi-square and t tests for demographic comparisons, and Cox proportional hazards models for evaluating the risk of IBD development, with adjustments for various co -morbidities and demographic factors. Results: The study included 5825 AS patients and 28,356 controls. AS patients demonstrated a significantly higher incidence of IBD with hazard ratios of 6.09 for Crohn's disease and 2.31 for ulcerative colitis, after multivariate adjustment. The overall incidence of IBD in the AS cohort was significantly higher compared to controls. Conclusions: AS patients exhibit a markedly increased risk of developing IBD. These findings advocate for heightened clinical vigilance for IBD symptoms in AS patients and suggest the need for a multidisciplinary approach to patient care. Further research into the shared pathogenic pathways is needed to develop personalized treatment strategies and improve patient management.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 50 条
  • [41] Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease
    James T. Rosenbaum
    Clinical Rheumatology, 2015, 34 : 999 - 1002
  • [42] Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease
    Rosenbaum, James T.
    CLINICAL RHEUMATOLOGY, 2015, 34 (06) : 999 - 1002
  • [43] The immune response to Klebsiella pneumoniae in inflammatory bowel disease and ankylosing spondylitis.
    Walmsley, RS
    Tiwana, H
    Wilson, C
    Hudson, MJ
    Ebringer, A
    Pounder, RE
    Wakefield, AJ
    GUT, 1997, 40 : W98 - W98
  • [44] The immune response to Klebsiella pneumoniae in inflammatory bowel disease and ankylosing spondylitis.
    Walmsley, RS
    Tiwana, H
    Wilson, C
    Hudson, MJ
    Ebringer, A
    Pounder, RE
    Wakefield, AJ
    GASTROENTEROLOGY, 1997, 112 (04) : A1115 - A1115
  • [45] THE CONCOMITANCE OF INFLAMMATORY BOWEL DISEASE WITH INCIDENT RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN FINLAND
    Puolakka, K.
    Rantalaiho, V.
    Kautiainen, H.
    Farkkila, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 403 - 404
  • [46] SERUM LEVELS OF INFLAMMATORY BOWEL DISEASE-SPECIFIC ANTIBODIES IN ANKYLOSING SPONDYLITIS
    Aleksandrova, E.
    Novikov, A.
    Kulakova, P.
    Koltsova, E.
    Klimets, A.
    Savenkova, N.
    Volnukhin, E.
    Kovshik, A.
    Lukina, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1843 - 1843
  • [47] Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort study
    Villatoro-Villar, M.
    Crowson, C. S.
    Warrington, K. J.
    Makol, A.
    Koster, M. J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 (01) : 40 - 47
  • [48] RISK FACTORS FOR UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: A RETROSPECTIVE COHORT STUDY
    Lee, E. E.
    Kim, M. J.
    Lee, E. Y.
    Song, Y. W.
    Lee, E. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 652 - 652
  • [49] THE FREQUENCY OF INFLAMMATORY BOWEL DISEASES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Lukina, G.
    Kulakova, P.
    Savenkova, N.
    Volnukhin, E.
    Kovshik, A.
    Alexandrova, E.
    Novikov, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1643 - 1643
  • [50] Gut Microbiome Changes Are Different Between Ankylosing Spondylitis and Inflammatory Bowel Disease, and Correlate with Disease Activity in Both Diseases
    Sternes, Peter
    Brett, Laurel
    Phipps, Julie
    Ciccia, Francesco
    de Guzman, Erika
    Morrison, Mark
    Holtmann, Gerald
    Klingberg, Eva
    McIvor, Carolyn
    Forsblad-d'Elia, Helena
    Brown, Matthew
    ARTHRITIS & RHEUMATOLOGY, 2020, 72